Densitometric analysis indicated that low-and high-ArCC treatment decreased VCAM-1 levels compared with those of WD ApoE−/− mice (74.6 ± 8 and 18.45 ± 5, vs. 100.00, respectively, p < 0.05). Here, VCAM1 is linked to Wilson disease.